Beiersdorf Aktiengesellschaft (LON:0DQ7)
London · Delayed Price · Currency is GBP · Price in EUR | Market Cap | 14.33B -22.4% |
| Revenue (ttm) | 8.28B -2.5% |
| Net Income | 807.69M +6.3% |
| EPS | 3.69 +8.6% |
| Shares Out | n/a |
| PE Ratio | 17.75 |
| Forward PE | 19.61 |
| Dividend | 0.87 (1.32%) |
| Ex-Dividend Date | Apr 24, 2026 |
| Volume | 132 |
| Open | 75.92 |
| Previous Close | 76.32 |
| Day's Range | 75.44 - 76.34 |
| 52-Week Range | 67.10 - 110.20 |
| Beta | 0.49 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 27, 2026 |
About LON:0DQ7
Beiersdorf Aktiengesellschaft, together with its subsidiaries, manufactures and distributes consumer goods in Europe, the United States, Africa, Asia, and Australia. The company operates through two segments: Consumer Business and Tesa Business. The Consumer Business Segment offers skin and body care products. The Tesa Business segment provides adhesive tapes and self-adhesive solutions for industries, craft businesses, and consumers. This segment also offers its system solutions to the automotive, consumer electronics, printing and packaging, ... [Read more]
Financial Performance
In 2025, LON:0DQ7's revenue was 9.85 billion, an increase of 0.02% compared to the previous year's 9.85 billion. Earnings were 939.00 million, an increase of 2.96%.
Financial numbers in EUR Financial StatementsNews
EQS-NVR: Beiersdorf AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Total Voting Rights Announcement: Beiersdorf Aktiengesellschaft / Total Voting Rights Announcement Beiersdorf AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] wi...
Nunavik police officer faces assault charges following BEI investigation
A Nunavik police officer is facing charges of assault and assault with a weapon following an investigation by Quebec’s police watchdog. The alleged offences took place in Umiujaq in northern Quebec on...
EQS-CMS: Beiersdorf Aktiengesellschaft: Release of a capital market information
EQS Post-admission Duties announcement: Beiersdorf Aktiengesellschaft / Announcement pursuant to Article 5 para. 1 lit. a) of Regulation (EU) No. 596/2014 and Article 2 para. 1 of the Delegated Regula...
Beiersdorf Aktiengesellschaft Q2 Earnings Call Highlights
Beiersdorf Aktiengesellschaft ETR: BEI reported a weaker first half of 2026 as continued pressure at NIVEA outweighed growth in its Derma and Healthcare businesses. The company lowered its full-year o...
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q2 2026
H1 2026 saw group sales decline 3.5% organically, with NIVEA underperforming but Derma and Healthcare segments delivering strong growth. An 18-month NIVEA turnaround plan and increased marketing investment aim to restore growth, while guidance for 2026 was lowered amid ongoing market volatility.
Beiersdorf Aktiengesellschaft Earnings release: Q2 2026
Beiersdorf Aktiengesellschaft released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
Beiersdorf Aktiengesellschaft Quarterly report: Q2 2026
Beiersdorf Aktiengesellschaft has published its Q2 2026 quarterly earnings report on August 5, 2026.
Beiersdorf Aktiengesellschaft Slides: Q2 2026
Beiersdorf Aktiengesellschaft has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 5, 2026.
Beiersdorf says Middle East conflict disrupts Gulf sales, deliveries
Nivea-maker Beiersdorf said conflict in the Middle East is disrupting both sales and deliveries in key Gulf markets, highlighting how geopolitical tensions continue to affect consumer-goods companie...
Nivea-maker Beiersdorf cuts sales guidance for 2026
Beiersdorf trimmed its guidance on Monday and now expects an organic sales decline in the low-single digit percentage range this year.
Beiersdorf Aktiengesellschaft Transcript: AGM 2026
The AGM highlighted solid financial results amid a challenging market, with strategic focus on NIVEA's repositioning, innovation, and expansion in key markets. Shareholders approved all proposals, including a EUR 1 dividend and share buyback, while management addressed concerns on growth, acquisitions, and remuneration.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q1 2026
Q1 2026 saw a 4.6% organic net sales decline, with Derma delivering strong growth and Nivea and La Prairie facing headwinds. Early signs of improved sell-out and ongoing strategic rebalancing support a cautiously optimistic outlook for the year.
Beiersdorf Aktiengesellschaft Earnings release: Q1 2026
Beiersdorf Aktiengesellschaft released its Q1 2026 earnings on April 21, 2026, summarizing the period's financial results.
Beiersdorf Aktiengesellschaft Slides: Q1 2026
Beiersdorf Aktiengesellschaft has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 21, 2026.
Is Beiersdorf stock a buy after 44% crash? UBS upgrade offers key signals
Beiersdorf stock's long slump has finally been enough to make one major broker step back from its bearish stance. UBS upgraded the German skincare and consumer-goods group to “neutral” from “sell” on ...
Beiersdorf Shares Fall on Sluggish 2026 Outlook
The cosmetics company expects slow sales this year, particularly in its consumer business segment.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q4 2025
Despite a challenging year marked by market slowdowns and cost pressures, the group delivered modest sales and profit growth, driven by strong Derma performance and innovation. Strategic repositioning of NIVEA and continued investment in R&D and shareholder returns are key priorities.
Beiersdorf Aktiengesellschaft Annual report: Q4 2025
Beiersdorf Aktiengesellschaft has published its Q4 2025 annual report on March 3, 2026.
Beiersdorf Aktiengesellschaft Earnings release: Q4 2025
Beiersdorf Aktiengesellschaft released its Q4 2025 earnings on March 3, 2026, summarizing the period's financial results.
Beiersdorf Aktiengesellschaft Slides: Q4 2025
Beiersdorf Aktiengesellschaft has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 3, 2026.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q3 2025
Group organic sales grew 1.7% in Q3, led by double-digit derma growth, while NIVEA faced mass market headwinds but saw strong September momentum from new launches. Full-year guidance was adjusted to 2.5% organic growth, with EBIT margin improvement expected.
Beiersdorf Aktiengesellschaft Earnings release: Q3 2025
Beiersdorf Aktiengesellschaft released its Q3 2025 earnings on October 23, 2025, summarizing the period's financial results.
Beiersdorf Aktiengesellschaft Slides: Q3 2025
Beiersdorf Aktiengesellschaft has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 23, 2025.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q2 2025
Group organic sales grew 2.1% in H1 2025, with strong Derma and Healthcare segments offsetting NIVEA's softness. Major innovation launches, especially EPICELLINE, are set to drive a stronger H2, though full-year Consumer growth guidance was lowered to 3%-4%.
Beiersdorf Aktiengesellschaft Quarterly report: Q2 2025
Beiersdorf Aktiengesellschaft has published its Q2 2025 quarterly earnings report on August 6, 2025.